Trivitron Healthcare Private Limited, India-based medical technology company, has announced to launch Trivitron Healthcare Africa BV (THA) for the African continent, with headquarter in Dubai in its first phase of operations
Together with the Investment Funds for Health in Africa (IFHA), a leading private equity investor in the healthcare sector in Africa, THA aims to provide medical devices and instruments with after-sales service support across Africa, thereby improving access of medical equipment across the continent.
With the direct presence in Dubai, THA is set to provide sales and service infrastructure in four major hubs including Nairobi, Johannesburg, Lagos and Algiers. The company is expected to leverage these hubs to support neighbouring countries and manage an extensive channel partner network across the African continent.
THA’s initial offering will include a complete range of products and after-sales service support in laboratory medicine, medical imaging, critical care, operating room and renal care. The company said that it will distribute and support products manufactured by Trivitron in their nine USFDA, CE certified factories in India, Finland and Turkey.
THA is working with a leading healthcare group in East Africa to support the design and equipping of its new flagship hospital in Nairobi, Kenya. The company will also have a Multi-Vendor Biomedical Engineering Services division to ensure support for healthcare providers across Africa and focus on academic initiatives.
Max Coppoolse, managing partner of IFHA, said, “IFHA has long seen an opportunity to improve access to quality healthcare services by creating a provider of high-quality, affordable medical equipment and services. IFHA is excited to partner with Trivitron and IFC to turn this vision into a reality.”
